Tag: Tildrakizumab

PsoBest registry: Biologics dominate treatment for moderate-to-severe psoriasis

Presented By
Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany
Trial
PsoBest registry
Conference
EADV 2024
Type
Peer-reviewed article

6 November 2024 12:23

Psoriatic arthritis: Guidelines and best practice

Trial
Phase 3, BE ACTIVE, PATERA
Conference
WPPAC 2021
Type
Peer-reviewed article

17 September 2021 11:19

Selective IL-23 blocker safe in elderly psoriasis patients

Presented By
Prof. Peter van de Kerkhof, Radboudumc, the Netherlands
Trial
reSURFACE
Conference
AAD 2020
Type
Peer-reviewed article

19 August 2020 13:18

Novel selective IL-23 blocker equally effective in patients with metabolic syndrome

Presented By
Dr Alice Gottlieb, Tufts University School of Medicine, USA
Trial
reSURFACE 1 and 2
Conference
EADV 2019
Type
Peer-reviewed article

9 October 2019 17:28

Psoriasis and Biologics: The Beat Goes On

Presented By
Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA
Conference
AAD 2019
Type
Peer-reviewed article

19 April 2019 14:06
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com